Global Dental Anti-inflammatory Drugs Market Growth 2026-2032
The global Dental Anti-inflammatory Drugs market size is predicted to grow from US$ 1236 million in 2025 to US$ 1767 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.
In 2025, the global production of dental anti-inflammatory drugs reached approximately 115 million units, with an average global market price of around US$11 per unit. In the same year, the global total production capacity of dental anti-inflammatory drugs reached 143 million units. The industry average gross profit margin of this product reached 42%.Dental anti-inflammatory drugs refer to drugs specifically used to prevent or treat oral inflammation, infection and related postoperative symptoms. These drugs are widely used in periodontitis, root canal treatment, post-extraction care and other scenarios by inhibiting bacterial growth, reducing redness, swelling and pain, or promoting mucosal repair.
The upstream segment of the dental anti-inflammatory drug industry chain primarily comprises suppliers of active pharmaceutical ingredients (APIs), plant extracts and other active components, pharmaceutical excipients, packaging materials, and pharmaceutical manufacturing equipment; these involve various raw material categories such as antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and local antimicrobial/anti-inflammatory agents. The midstream segment consists mainly of R&D and manufacturing enterprises that handle formulation design, API preparation or procurement, finished product manufacturing, quality control, regulatory filing, and packaging; product forms include tablets, capsules, oral solutions, gels, mouthwashes, sprays, and injections. The downstream segment reaches dental hospitals, dental departments in general hospitals, dental clinics, and the home-use market through channels such as pharmaceutical distributors, hospital pharmacies, retail pharmacies, and e-commerce platforms. These drugs are ultimately used to manage conditions including odontogenic infections, periodontal inflammation, pericoronitis, and oral soft tissue inflammation, as well as to control inflammation and pain following dental surgery. The entire industry chain is collectively influenced by pharmaceutical regulations, clinical medication guidelines, policies on the rational use of antibiotics, and shifting demands for oral healthcare services.
Driven by the aging global population, the persistent burden of dental caries and periodontal disease, the rising volume of dental implants and oral surgeries, and increased public awareness of oral health and dental visit rates, dental anti-inflammatory drugs maintain stable clinical demand. However, the industry's growth logic is shifting from the mere expansion of antibiotic use toward standardized, precision, and localized treatment approaches. Future use of systemic antibiotics will face stricter constraints regarding antimicrobial resistance management and prescribing protocols, while products featuring local administration, targeted release, low systemic exposure, and combined anti-inflammatory and analgesic properties are poised for wider adoption. Concurrently, key R&D directions will focus on local periodontal drug delivery systems, novel antimicrobial materials, sustained- and controlled-release formulations, and products offering combined anti-inflammatory, antimicrobial, and tissue-repair capabilities. Overall, the dental anti-inflammatory drug market is expected to experience moderate growth, with the product mix gradually evolving toward options that offer enhanced safety, stronger local efficacy, greater convenience, and more clearly defined clinical indications.
This Insight Report provides a comprehensive analysis of the global Dental Anti-inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dental Anti-inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dental Anti-inflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dental Anti-inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dental Anti-inflammatory Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Dental Anti-inflammatory Drugs market by product type, application, key manufacturers and key regions and countries.
In 2025, the global production of dental anti-inflammatory drugs reached approximately 115 million units, with an average global market price of around US$11 per unit. In the same year, the global total production capacity of dental anti-inflammatory drugs reached 143 million units. The industry average gross profit margin of this product reached 42%.Dental anti-inflammatory drugs refer to drugs specifically used to prevent or treat oral inflammation, infection and related postoperative symptoms. These drugs are widely used in periodontitis, root canal treatment, post-extraction care and other scenarios by inhibiting bacterial growth, reducing redness, swelling and pain, or promoting mucosal repair.
The upstream segment of the dental anti-inflammatory drug industry chain primarily comprises suppliers of active pharmaceutical ingredients (APIs), plant extracts and other active components, pharmaceutical excipients, packaging materials, and pharmaceutical manufacturing equipment; these involve various raw material categories such as antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), and local antimicrobial/anti-inflammatory agents. The midstream segment consists mainly of R&D and manufacturing enterprises that handle formulation design, API preparation or procurement, finished product manufacturing, quality control, regulatory filing, and packaging; product forms include tablets, capsules, oral solutions, gels, mouthwashes, sprays, and injections. The downstream segment reaches dental hospitals, dental departments in general hospitals, dental clinics, and the home-use market through channels such as pharmaceutical distributors, hospital pharmacies, retail pharmacies, and e-commerce platforms. These drugs are ultimately used to manage conditions including odontogenic infections, periodontal inflammation, pericoronitis, and oral soft tissue inflammation, as well as to control inflammation and pain following dental surgery. The entire industry chain is collectively influenced by pharmaceutical regulations, clinical medication guidelines, policies on the rational use of antibiotics, and shifting demands for oral healthcare services.
Driven by the aging global population, the persistent burden of dental caries and periodontal disease, the rising volume of dental implants and oral surgeries, and increased public awareness of oral health and dental visit rates, dental anti-inflammatory drugs maintain stable clinical demand. However, the industry's growth logic is shifting from the mere expansion of antibiotic use toward standardized, precision, and localized treatment approaches. Future use of systemic antibiotics will face stricter constraints regarding antimicrobial resistance management and prescribing protocols, while products featuring local administration, targeted release, low systemic exposure, and combined anti-inflammatory and analgesic properties are poised for wider adoption. Concurrently, key R&D directions will focus on local periodontal drug delivery systems, novel antimicrobial materials, sustained- and controlled-release formulations, and products offering combined anti-inflammatory, antimicrobial, and tissue-repair capabilities. Overall, the dental anti-inflammatory drug market is expected to experience moderate growth, with the product mix gradually evolving toward options that offer enhanced safety, stronger local efficacy, greater convenience, and more clearly defined clinical indications.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Dental Anti-inflammatory Drugs Industry Forecast” looks at past sales and reviews total world Dental Anti-inflammatory Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Dental Anti-inflammatory Drugs sales for 2026 through 2032. With Dental Anti-inflammatory Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dental Anti-inflammatory Drugs industry.This Insight Report provides a comprehensive analysis of the global Dental Anti-inflammatory Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dental Anti-inflammatory Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dental Anti-inflammatory Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dental Anti-inflammatory Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dental Anti-inflammatory Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Dental Anti-inflammatory Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Oral Rinse
- Oral Gel/Ointment
- Oral Spray
- Oral Tablets
- Oral Powder
- Others
Segmentation by Number of Active Ingredients:
- Single-Active-Ingredient Type (1 Active Ingredient)
- Multi-Active-Ingredient Type (?2 Active Ingredients)
Segmentation by Pharmacological Action:
- Antimicrobial
- Anti-inflammatory
- Combined Antimicrobial and Anti-inflammatory
- Tissue Repair
- Others
Segmentation by Application:
- Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
- Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
- Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
- Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Haleon
- Taro Pharmaceuticals
- iNova Pharmaceuticals
- Lion Corporation
- Sato Pharmaceutical
- Daiichi Sankyo Healthcare
- Rohto Pharmaceutical
- Kobayashi Pharmaceutical
- Kowa Company
- Guilin Sanjin Pharmaceutical
- ICPA Health Products
- VistaPharm, Inc.
- Patterson Dental Supply, Inc.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Dental Anti-inflammatory Drugs market?
- What factors are driving Dental Anti-inflammatory Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Dental Anti-inflammatory Drugs market opportunities vary by end market size?
- How does Dental Anti-inflammatory Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dental Anti-inflammatory Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dental Anti-inflammatory Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dental Anti-inflammatory Drugs by Country/Region, 2021, 2025 & 2032
2.2 Dental Anti-inflammatory Drugs Segment by Type
2.2.1 Oral Rinse
2.2.2 Oral Gel/Ointment
2.2.3 Oral Spray
2.2.4 Oral Tablets
2.2.5 Oral Powder
2.2.6 Others
2.2.7 Dental Anti-inflammatory Drugs Sales by Type
2.2.7.1 Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
2.2.7.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Dental Anti-inflammatory Drugs Sale Price by Type (2021-2026)
2.3 Dental Anti-inflammatory Drugs Segment by Number of Active Ingredients
2.3.1 Single-Active-Ingredient Type (1 Active Ingredient)
2.3.2 Multi-Active-Ingredient Type (?2 Active Ingredients)
2.3.3 Dental Anti-inflammatory Drugs Sales by Number of Active Ingredients
2.3.3.1 Global Dental Anti-inflammatory Drugs Sales Market Share by Number of Active Ingredients (2021-2026)
2.3.3.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Number of Active Ingredients (2021-2026)
2.3.3.3 Global Dental Anti-inflammatory Drugs Sale Price by Number of Active Ingredients (2021-2026)
2.4 Dental Anti-inflammatory Drugs Segment by Pharmacological Action
2.4.1 Antimicrobial
2.4.2 Anti-inflammatory
2.4.3 Combined Antimicrobial and Anti-inflammatory
2.4.4 Tissue Repair
2.4.5 Others
2.4.6 Dental Anti-inflammatory Drugs Sales by Pharmacological Action
2.4.6.1 Global Dental Anti-inflammatory Drugs Sales Market Share by Pharmacological Action (2021-2026)
2.4.6.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Pharmacological Action (2021-2026)
2.4.6.3 Global Dental Anti-inflammatory Drugs Sale Price by Pharmacological Action (2021-2026)
2.5 Dental Anti-inflammatory Drugs Segment by Application
2.5.1 Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
2.5.2 Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
2.5.3 Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
2.5.4 Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
2.5.5 Others
2.5.6 Dental Anti-inflammatory Drugs Sales by Application
2.5.6.1 Global Dental Anti-inflammatory Drugs Sale Market Share by Application (2021-2026)
2.5.6.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Dental Anti-inflammatory Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dental Anti-inflammatory Drugs Breakdown Data by Company
3.1.1 Global Dental Anti-inflammatory Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Dental Anti-inflammatory Drugs Sales Market Share by Company (2021-2026)
3.2 Global Dental Anti-inflammatory Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Dental Anti-inflammatory Drugs Revenue by Company (2021-2026)
3.2.2 Global Dental Anti-inflammatory Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Dental Anti-inflammatory Drugs Sale Price by Company
3.4 Key Manufacturers Dental Anti-inflammatory Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dental Anti-inflammatory Drugs Product Location Distribution
3.4.2 Players Dental Anti-inflammatory Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DENTAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Dental Anti-inflammatory Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Dental Anti-inflammatory Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dental Anti-inflammatory Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dental Anti-inflammatory Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Dental Anti-inflammatory Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dental Anti-inflammatory Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dental Anti-inflammatory Drugs Sales Growth
4.4 APAC Dental Anti-inflammatory Drugs Sales Growth
4.5 Europe Dental Anti-inflammatory Drugs Sales Growth
4.6 Middle East & Africa Dental Anti-inflammatory Drugs Sales Growth
5 AMERICAS
5.1 Americas Dental Anti-inflammatory Drugs Sales by Country
5.1.1 Americas Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
5.1.2 Americas Dental Anti-inflammatory Drugs Revenue by Country (2021-2026)
5.2 Americas Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
5.3 Americas Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dental Anti-inflammatory Drugs Sales by Region
6.1.1 APAC Dental Anti-inflammatory Drugs Sales by Region (2021-2026)
6.1.2 APAC Dental Anti-inflammatory Drugs Revenue by Region (2021-2026)
6.2 APAC Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
6.3 APAC Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dental Anti-inflammatory Drugs by Country
7.1.1 Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
7.1.2 Europe Dental Anti-inflammatory Drugs Revenue by Country (2021-2026)
7.2 Europe Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
7.3 Europe Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dental Anti-inflammatory Drugs by Country
8.1.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dental Anti-inflammatory Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dental Anti-inflammatory Drugs
10.3 Manufacturing Process Analysis of Dental Anti-inflammatory Drugs
10.4 Industry Chain Structure of Dental Anti-inflammatory Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dental Anti-inflammatory Drugs Distributors
11.3 Dental Anti-inflammatory Drugs Customer
12 WORLD FORECAST REVIEW FOR DENTAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
12.1 Global Dental Anti-inflammatory Drugs Market Size Forecast by Region
12.1.1 Global Dental Anti-inflammatory Drugs Forecast by Region (2027-2032)
12.1.2 Global Dental Anti-inflammatory Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dental Anti-inflammatory Drugs Forecast by Type (2027-2032)
12.7 Global Dental Anti-inflammatory Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Haleon
13.1.1 Haleon Company Information
13.1.2 Haleon Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.1.3 Haleon Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Haleon Main Business Overview
13.1.5 Haleon Latest Developments
13.2 Taro Pharmaceuticals
13.2.1 Taro Pharmaceuticals Company Information
13.2.2 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.2.3 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Taro Pharmaceuticals Main Business Overview
13.2.5 Taro Pharmaceuticals Latest Developments
13.3 iNova Pharmaceuticals
13.3.1 iNova Pharmaceuticals Company Information
13.3.2 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.3.3 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 iNova Pharmaceuticals Main Business Overview
13.3.5 iNova Pharmaceuticals Latest Developments
13.4 Lion Corporation
13.4.1 Lion Corporation Company Information
13.4.2 Lion Corporation Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.4.3 Lion Corporation Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lion Corporation Main Business Overview
13.4.5 Lion Corporation Latest Developments
13.5 Sato Pharmaceutical
13.5.1 Sato Pharmaceutical Company Information
13.5.2 Sato Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.5.3 Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sato Pharmaceutical Main Business Overview
13.5.5 Sato Pharmaceutical Latest Developments
13.6 Daiichi Sankyo Healthcare
13.6.1 Daiichi Sankyo Healthcare Company Information
13.6.2 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.6.3 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Daiichi Sankyo Healthcare Main Business Overview
13.6.5 Daiichi Sankyo Healthcare Latest Developments
13.7 Rohto Pharmaceutical
13.7.1 Rohto Pharmaceutical Company Information
13.7.2 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.7.3 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Rohto Pharmaceutical Main Business Overview
13.7.5 Rohto Pharmaceutical Latest Developments
13.8 Kobayashi Pharmaceutical
13.8.1 Kobayashi Pharmaceutical Company Information
13.8.2 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.8.3 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kobayashi Pharmaceutical Main Business Overview
13.8.5 Kobayashi Pharmaceutical Latest Developments
13.9 Kowa Company
13.9.1 Kowa Company Company Information
13.9.2 Kowa Company Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.9.3 Kowa Company Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Kowa Company Main Business Overview
13.9.5 Kowa Company Latest Developments
13.10 Guilin Sanjin Pharmaceutical
13.10.1 Guilin Sanjin Pharmaceutical Company Information
13.10.2 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.10.3 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Guilin Sanjin Pharmaceutical Main Business Overview
13.10.5 Guilin Sanjin Pharmaceutical Latest Developments
13.11 ICPA Health Products
13.11.1 ICPA Health Products Company Information
13.11.2 ICPA Health Products Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.11.3 ICPA Health Products Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ICPA Health Products Main Business Overview
13.11.5 ICPA Health Products Latest Developments
13.12 VistaPharm, Inc.
13.12.1 VistaPharm, Inc. Company Information
13.12.2 VistaPharm, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.12.3 VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 VistaPharm, Inc. Main Business Overview
13.12.5 VistaPharm, Inc. Latest Developments
13.13 Patterson Dental Supply, Inc.
13.13.1 Patterson Dental Supply, Inc. Company Information
13.13.2 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.13.3 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Patterson Dental Supply, Inc. Main Business Overview
13.13.5 Patterson Dental Supply, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dental Anti-inflammatory Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Dental Anti-inflammatory Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Dental Anti-inflammatory Drugs by Country/Region, 2021, 2025 & 2032
2.2 Dental Anti-inflammatory Drugs Segment by Type
2.2.1 Oral Rinse
2.2.2 Oral Gel/Ointment
2.2.3 Oral Spray
2.2.4 Oral Tablets
2.2.5 Oral Powder
2.2.6 Others
2.2.7 Dental Anti-inflammatory Drugs Sales by Type
2.2.7.1 Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
2.2.7.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Dental Anti-inflammatory Drugs Sale Price by Type (2021-2026)
2.3 Dental Anti-inflammatory Drugs Segment by Number of Active Ingredients
2.3.1 Single-Active-Ingredient Type (1 Active Ingredient)
2.3.2 Multi-Active-Ingredient Type (?2 Active Ingredients)
2.3.3 Dental Anti-inflammatory Drugs Sales by Number of Active Ingredients
2.3.3.1 Global Dental Anti-inflammatory Drugs Sales Market Share by Number of Active Ingredients (2021-2026)
2.3.3.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Number of Active Ingredients (2021-2026)
2.3.3.3 Global Dental Anti-inflammatory Drugs Sale Price by Number of Active Ingredients (2021-2026)
2.4 Dental Anti-inflammatory Drugs Segment by Pharmacological Action
2.4.1 Antimicrobial
2.4.2 Anti-inflammatory
2.4.3 Combined Antimicrobial and Anti-inflammatory
2.4.4 Tissue Repair
2.4.5 Others
2.4.6 Dental Anti-inflammatory Drugs Sales by Pharmacological Action
2.4.6.1 Global Dental Anti-inflammatory Drugs Sales Market Share by Pharmacological Action (2021-2026)
2.4.6.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Pharmacological Action (2021-2026)
2.4.6.3 Global Dental Anti-inflammatory Drugs Sale Price by Pharmacological Action (2021-2026)
2.5 Dental Anti-inflammatory Drugs Segment by Application
2.5.1 Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
2.5.2 Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
2.5.3 Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
2.5.4 Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
2.5.5 Others
2.5.6 Dental Anti-inflammatory Drugs Sales by Application
2.5.6.1 Global Dental Anti-inflammatory Drugs Sale Market Share by Application (2021-2026)
2.5.6.2 Global Dental Anti-inflammatory Drugs Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Dental Anti-inflammatory Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Dental Anti-inflammatory Drugs Breakdown Data by Company
3.1.1 Global Dental Anti-inflammatory Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Dental Anti-inflammatory Drugs Sales Market Share by Company (2021-2026)
3.2 Global Dental Anti-inflammatory Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Dental Anti-inflammatory Drugs Revenue by Company (2021-2026)
3.2.2 Global Dental Anti-inflammatory Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Dental Anti-inflammatory Drugs Sale Price by Company
3.4 Key Manufacturers Dental Anti-inflammatory Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dental Anti-inflammatory Drugs Product Location Distribution
3.4.2 Players Dental Anti-inflammatory Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DENTAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Dental Anti-inflammatory Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Dental Anti-inflammatory Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Dental Anti-inflammatory Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Dental Anti-inflammatory Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Dental Anti-inflammatory Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Dental Anti-inflammatory Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Dental Anti-inflammatory Drugs Sales Growth
4.4 APAC Dental Anti-inflammatory Drugs Sales Growth
4.5 Europe Dental Anti-inflammatory Drugs Sales Growth
4.6 Middle East & Africa Dental Anti-inflammatory Drugs Sales Growth
5 AMERICAS
5.1 Americas Dental Anti-inflammatory Drugs Sales by Country
5.1.1 Americas Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
5.1.2 Americas Dental Anti-inflammatory Drugs Revenue by Country (2021-2026)
5.2 Americas Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
5.3 Americas Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dental Anti-inflammatory Drugs Sales by Region
6.1.1 APAC Dental Anti-inflammatory Drugs Sales by Region (2021-2026)
6.1.2 APAC Dental Anti-inflammatory Drugs Revenue by Region (2021-2026)
6.2 APAC Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
6.3 APAC Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dental Anti-inflammatory Drugs by Country
7.1.1 Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
7.1.2 Europe Dental Anti-inflammatory Drugs Revenue by Country (2021-2026)
7.2 Europe Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
7.3 Europe Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dental Anti-inflammatory Drugs by Country
8.1.1 Middle East & Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Dental Anti-inflammatory Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Dental Anti-inflammatory Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Dental Anti-inflammatory Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dental Anti-inflammatory Drugs
10.3 Manufacturing Process Analysis of Dental Anti-inflammatory Drugs
10.4 Industry Chain Structure of Dental Anti-inflammatory Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dental Anti-inflammatory Drugs Distributors
11.3 Dental Anti-inflammatory Drugs Customer
12 WORLD FORECAST REVIEW FOR DENTAL ANTI-INFLAMMATORY DRUGS BY GEOGRAPHIC REGION
12.1 Global Dental Anti-inflammatory Drugs Market Size Forecast by Region
12.1.1 Global Dental Anti-inflammatory Drugs Forecast by Region (2027-2032)
12.1.2 Global Dental Anti-inflammatory Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Dental Anti-inflammatory Drugs Forecast by Type (2027-2032)
12.7 Global Dental Anti-inflammatory Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Haleon
13.1.1 Haleon Company Information
13.1.2 Haleon Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.1.3 Haleon Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Haleon Main Business Overview
13.1.5 Haleon Latest Developments
13.2 Taro Pharmaceuticals
13.2.1 Taro Pharmaceuticals Company Information
13.2.2 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.2.3 Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Taro Pharmaceuticals Main Business Overview
13.2.5 Taro Pharmaceuticals Latest Developments
13.3 iNova Pharmaceuticals
13.3.1 iNova Pharmaceuticals Company Information
13.3.2 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.3.3 iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 iNova Pharmaceuticals Main Business Overview
13.3.5 iNova Pharmaceuticals Latest Developments
13.4 Lion Corporation
13.4.1 Lion Corporation Company Information
13.4.2 Lion Corporation Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.4.3 Lion Corporation Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lion Corporation Main Business Overview
13.4.5 Lion Corporation Latest Developments
13.5 Sato Pharmaceutical
13.5.1 Sato Pharmaceutical Company Information
13.5.2 Sato Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.5.3 Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sato Pharmaceutical Main Business Overview
13.5.5 Sato Pharmaceutical Latest Developments
13.6 Daiichi Sankyo Healthcare
13.6.1 Daiichi Sankyo Healthcare Company Information
13.6.2 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.6.3 Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Daiichi Sankyo Healthcare Main Business Overview
13.6.5 Daiichi Sankyo Healthcare Latest Developments
13.7 Rohto Pharmaceutical
13.7.1 Rohto Pharmaceutical Company Information
13.7.2 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.7.3 Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Rohto Pharmaceutical Main Business Overview
13.7.5 Rohto Pharmaceutical Latest Developments
13.8 Kobayashi Pharmaceutical
13.8.1 Kobayashi Pharmaceutical Company Information
13.8.2 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.8.3 Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Kobayashi Pharmaceutical Main Business Overview
13.8.5 Kobayashi Pharmaceutical Latest Developments
13.9 Kowa Company
13.9.1 Kowa Company Company Information
13.9.2 Kowa Company Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.9.3 Kowa Company Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Kowa Company Main Business Overview
13.9.5 Kowa Company Latest Developments
13.10 Guilin Sanjin Pharmaceutical
13.10.1 Guilin Sanjin Pharmaceutical Company Information
13.10.2 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.10.3 Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Guilin Sanjin Pharmaceutical Main Business Overview
13.10.5 Guilin Sanjin Pharmaceutical Latest Developments
13.11 ICPA Health Products
13.11.1 ICPA Health Products Company Information
13.11.2 ICPA Health Products Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.11.3 ICPA Health Products Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 ICPA Health Products Main Business Overview
13.11.5 ICPA Health Products Latest Developments
13.12 VistaPharm, Inc.
13.12.1 VistaPharm, Inc. Company Information
13.12.2 VistaPharm, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.12.3 VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 VistaPharm, Inc. Main Business Overview
13.12.5 VistaPharm, Inc. Latest Developments
13.13 Patterson Dental Supply, Inc.
13.13.1 Patterson Dental Supply, Inc. Company Information
13.13.2 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
13.13.3 Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Patterson Dental Supply, Inc. Main Business Overview
13.13.5 Patterson Dental Supply, Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dental Anti-inflammatory Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dental Anti-inflammatory Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Rinse
Table 4. Major Players of Oral Gel/Ointment
Table 5. Major Players of Oral Spray
Table 6. Major Players of Oral Tablets
Table 7. Major Players of Oral Powder
Table 8. Major Players of Others
Table 9. Global Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 10. Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Table 11. Global Dental Anti-inflammatory Drugs Revenue by Type (2021-2026) & ($ million)
Table 12. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2026)
Table 13. Global Dental Anti-inflammatory Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Major Players of Single-Active-Ingredient Type (1 Active Ingredient)
Table 15. Major Players of Multi-Active-Ingredient Type (?2 Active Ingredients)
Table 16. Global Dental Anti-inflammatory Drugs Sales by Number of Active Ingredients (2021-2026) & (K Units)
Table 17. Global Dental Anti-inflammatory Drugs Sales Market Share by Number of Active Ingredients (2021-2026)
Table 18. Global Dental Anti-inflammatory Drugs Revenue by Number of Active Ingredients (2021-2026) & ($ million)
Table 19. Global Dental Anti-inflammatory Drugs Revenue Market Share by Number of Active Ingredients (2021-2026)
Table 20. Global Dental Anti-inflammatory Drugs Sale Price by Number of Active Ingredients (2021-2026) & (US$/Unit)
Table 21. Major Players of Antimicrobial
Table 22. Major Players of Anti-inflammatory
Table 23. Major Players of Combined Antimicrobial and Anti-inflammatory
Table 24. Major Players of Tissue Repair
Table 25. Major Players of Others
Table 26. Global Dental Anti-inflammatory Drugs Sales by Pharmacological Action (2021-2026) & (K Units)
Table 27. Global Dental Anti-inflammatory Drugs Sales Market Share by Pharmacological Action (2021-2026)
Table 28. Global Dental Anti-inflammatory Drugs Revenue by Pharmacological Action (2021-2026) & ($ million)
Table 29. Global Dental Anti-inflammatory Drugs Revenue Market Share by Pharmacological Action (2021-2026)
Table 30. Global Dental Anti-inflammatory Drugs Sale Price by Pharmacological Action (2021-2026) & (US$/Unit)
Table 31. Global Dental Anti-inflammatory Drugs Sale by Application (2021-2026) & (K Units)
Table 32. Global Dental Anti-inflammatory Drugs Sale Market Share by Application (2021-2026)
Table 33. Global Dental Anti-inflammatory Drugs Revenue by Application (2021-2026) & ($ million)
Table 34. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2026)
Table 35. Global Dental Anti-inflammatory Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Dental Anti-inflammatory Drugs Sales by Company (2021-2026) & (K Units)
Table 37. Global Dental Anti-inflammatory Drugs Sales Market Share by Company (2021-2026)
Table 38. Global Dental Anti-inflammatory Drugs Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Dental Anti-inflammatory Drugs Revenue Market Share by Company (2021-2026)
Table 40. Global Dental Anti-inflammatory Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Dental Anti-inflammatory Drugs Producing Area Distribution and Sales Area
Table 42. Players Dental Anti-inflammatory Drugs Products Offered
Table 43. Dental Anti-inflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Dental Anti-inflammatory Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 47. Global Dental Anti-inflammatory Drugs Sales Market Share Geographic Region (2021-2026)
Table 48. Global Dental Anti-inflammatory Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Dental Anti-inflammatory Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Dental Anti-inflammatory Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 51. Global Dental Anti-inflammatory Drugs Sales Market Share by Country/Region (2021-2026)
Table 52. Global Dental Anti-inflammatory Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Dental Anti-inflammatory Drugs Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (K Units)
Table 55. Americas Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2026)
Table 56. Americas Dental Anti-inflammatory Drugs Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 58. Americas Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 59. APAC Dental Anti-inflammatory Drugs Sales by Region (2021-2026) & (K Units)
Table 60. APAC Dental Anti-inflammatory Drugs Sales Market Share by Region (2021-2026)
Table 61. APAC Dental Anti-inflammatory Drugs Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 63. APAC Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 64. Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (K Units)
Table 65. Europe Dental Anti-inflammatory Drugs Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 67. Europe Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Middle East & Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (K Units)
Table 69. Middle East & Africa Dental Anti-inflammatory Drugs Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 71. Middle East & Africa Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Key Market Drivers & Growth Opportunities of Dental Anti-inflammatory Drugs
Table 73. Key Market Challenges & Risks of Dental Anti-inflammatory Drugs
Table 74. Key Industry Trends of Dental Anti-inflammatory Drugs
Table 75. Dental Anti-inflammatory Drugs Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Dental Anti-inflammatory Drugs Distributors List
Table 78. Dental Anti-inflammatory Drugs Customer List
Table 79. Global Dental Anti-inflammatory Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 80. Global Dental Anti-inflammatory Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Americas Dental Anti-inflammatory Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Dental Anti-inflammatory Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 84. APAC Dental Anti-inflammatory Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Europe Dental Anti-inflammatory Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 88. Middle East & Africa Dental Anti-inflammatory Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Dental Anti-inflammatory Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 90. Global Dental Anti-inflammatory Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Dental Anti-inflammatory Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 92. Global Dental Anti-inflammatory Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. Haleon Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Haleon Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 95. Haleon Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Haleon Main Business
Table 97. Haleon Latest Developments
Table 98. Taro Pharmaceuticals Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 100. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Taro Pharmaceuticals Main Business
Table 102. Taro Pharmaceuticals Latest Developments
Table 103. iNova Pharmaceuticals Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 105. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. iNova Pharmaceuticals Main Business
Table 107. iNova Pharmaceuticals Latest Developments
Table 108. Lion Corporation Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Lion Corporation Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 110. Lion Corporation Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Lion Corporation Main Business
Table 112. Lion Corporation Latest Developments
Table 113. Sato Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sato Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 115. Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sato Pharmaceutical Main Business
Table 117. Sato Pharmaceutical Latest Developments
Table 118. Daiichi Sankyo Healthcare Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 120. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Daiichi Sankyo Healthcare Main Business
Table 122. Daiichi Sankyo Healthcare Latest Developments
Table 123. Rohto Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 125. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Rohto Pharmaceutical Main Business
Table 127. Rohto Pharmaceutical Latest Developments
Table 128. Kobayashi Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 130. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Kobayashi Pharmaceutical Main Business
Table 132. Kobayashi Pharmaceutical Latest Developments
Table 133. Kowa Company Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Kowa Company Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 135. Kowa Company Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Kowa Company Main Business
Table 137. Kowa Company Latest Developments
Table 138. Guilin Sanjin Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 140. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Guilin Sanjin Pharmaceutical Main Business
Table 142. Guilin Sanjin Pharmaceutical Latest Developments
Table 143. ICPA Health Products Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. ICPA Health Products Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 145. ICPA Health Products Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. ICPA Health Products Main Business
Table 147. ICPA Health Products Latest Developments
Table 148. VistaPharm, Inc. Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. VistaPharm, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 150. VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. VistaPharm, Inc. Main Business
Table 152. VistaPharm, Inc. Latest Developments
Table 153. Patterson Dental Supply, Inc. Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 155. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Patterson Dental Supply, Inc. Main Business
Table 157. Patterson Dental Supply, Inc. Latest Developments
Table 1. Dental Anti-inflammatory Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Dental Anti-inflammatory Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Rinse
Table 4. Major Players of Oral Gel/Ointment
Table 5. Major Players of Oral Spray
Table 6. Major Players of Oral Tablets
Table 7. Major Players of Oral Powder
Table 8. Major Players of Others
Table 9. Global Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 10. Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Table 11. Global Dental Anti-inflammatory Drugs Revenue by Type (2021-2026) & ($ million)
Table 12. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2026)
Table 13. Global Dental Anti-inflammatory Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Major Players of Single-Active-Ingredient Type (1 Active Ingredient)
Table 15. Major Players of Multi-Active-Ingredient Type (?2 Active Ingredients)
Table 16. Global Dental Anti-inflammatory Drugs Sales by Number of Active Ingredients (2021-2026) & (K Units)
Table 17. Global Dental Anti-inflammatory Drugs Sales Market Share by Number of Active Ingredients (2021-2026)
Table 18. Global Dental Anti-inflammatory Drugs Revenue by Number of Active Ingredients (2021-2026) & ($ million)
Table 19. Global Dental Anti-inflammatory Drugs Revenue Market Share by Number of Active Ingredients (2021-2026)
Table 20. Global Dental Anti-inflammatory Drugs Sale Price by Number of Active Ingredients (2021-2026) & (US$/Unit)
Table 21. Major Players of Antimicrobial
Table 22. Major Players of Anti-inflammatory
Table 23. Major Players of Combined Antimicrobial and Anti-inflammatory
Table 24. Major Players of Tissue Repair
Table 25. Major Players of Others
Table 26. Global Dental Anti-inflammatory Drugs Sales by Pharmacological Action (2021-2026) & (K Units)
Table 27. Global Dental Anti-inflammatory Drugs Sales Market Share by Pharmacological Action (2021-2026)
Table 28. Global Dental Anti-inflammatory Drugs Revenue by Pharmacological Action (2021-2026) & ($ million)
Table 29. Global Dental Anti-inflammatory Drugs Revenue Market Share by Pharmacological Action (2021-2026)
Table 30. Global Dental Anti-inflammatory Drugs Sale Price by Pharmacological Action (2021-2026) & (US$/Unit)
Table 31. Global Dental Anti-inflammatory Drugs Sale by Application (2021-2026) & (K Units)
Table 32. Global Dental Anti-inflammatory Drugs Sale Market Share by Application (2021-2026)
Table 33. Global Dental Anti-inflammatory Drugs Revenue by Application (2021-2026) & ($ million)
Table 34. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2021-2026)
Table 35. Global Dental Anti-inflammatory Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Dental Anti-inflammatory Drugs Sales by Company (2021-2026) & (K Units)
Table 37. Global Dental Anti-inflammatory Drugs Sales Market Share by Company (2021-2026)
Table 38. Global Dental Anti-inflammatory Drugs Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Dental Anti-inflammatory Drugs Revenue Market Share by Company (2021-2026)
Table 40. Global Dental Anti-inflammatory Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Dental Anti-inflammatory Drugs Producing Area Distribution and Sales Area
Table 42. Players Dental Anti-inflammatory Drugs Products Offered
Table 43. Dental Anti-inflammatory Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Dental Anti-inflammatory Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 47. Global Dental Anti-inflammatory Drugs Sales Market Share Geographic Region (2021-2026)
Table 48. Global Dental Anti-inflammatory Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Dental Anti-inflammatory Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Dental Anti-inflammatory Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 51. Global Dental Anti-inflammatory Drugs Sales Market Share by Country/Region (2021-2026)
Table 52. Global Dental Anti-inflammatory Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Dental Anti-inflammatory Drugs Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (K Units)
Table 55. Americas Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2026)
Table 56. Americas Dental Anti-inflammatory Drugs Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 58. Americas Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 59. APAC Dental Anti-inflammatory Drugs Sales by Region (2021-2026) & (K Units)
Table 60. APAC Dental Anti-inflammatory Drugs Sales Market Share by Region (2021-2026)
Table 61. APAC Dental Anti-inflammatory Drugs Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 63. APAC Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 64. Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (K Units)
Table 65. Europe Dental Anti-inflammatory Drugs Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 67. Europe Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Middle East & Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2026) & (K Units)
Table 69. Middle East & Africa Dental Anti-inflammatory Drugs Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Dental Anti-inflammatory Drugs Sales by Type (2021-2026) & (K Units)
Table 71. Middle East & Africa Dental Anti-inflammatory Drugs Sales by Application (2021-2026) & (K Units)
Table 72. Key Market Drivers & Growth Opportunities of Dental Anti-inflammatory Drugs
Table 73. Key Market Challenges & Risks of Dental Anti-inflammatory Drugs
Table 74. Key Industry Trends of Dental Anti-inflammatory Drugs
Table 75. Dental Anti-inflammatory Drugs Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Dental Anti-inflammatory Drugs Distributors List
Table 78. Dental Anti-inflammatory Drugs Customer List
Table 79. Global Dental Anti-inflammatory Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 80. Global Dental Anti-inflammatory Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Americas Dental Anti-inflammatory Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Dental Anti-inflammatory Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 84. APAC Dental Anti-inflammatory Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Europe Dental Anti-inflammatory Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 88. Middle East & Africa Dental Anti-inflammatory Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Dental Anti-inflammatory Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 90. Global Dental Anti-inflammatory Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Dental Anti-inflammatory Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 92. Global Dental Anti-inflammatory Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. Haleon Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Haleon Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 95. Haleon Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Haleon Main Business
Table 97. Haleon Latest Developments
Table 98. Taro Pharmaceuticals Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 100. Taro Pharmaceuticals Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Taro Pharmaceuticals Main Business
Table 102. Taro Pharmaceuticals Latest Developments
Table 103. iNova Pharmaceuticals Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 105. iNova Pharmaceuticals Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. iNova Pharmaceuticals Main Business
Table 107. iNova Pharmaceuticals Latest Developments
Table 108. Lion Corporation Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Lion Corporation Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 110. Lion Corporation Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Lion Corporation Main Business
Table 112. Lion Corporation Latest Developments
Table 113. Sato Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sato Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 115. Sato Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Sato Pharmaceutical Main Business
Table 117. Sato Pharmaceutical Latest Developments
Table 118. Daiichi Sankyo Healthcare Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 120. Daiichi Sankyo Healthcare Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Daiichi Sankyo Healthcare Main Business
Table 122. Daiichi Sankyo Healthcare Latest Developments
Table 123. Rohto Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 125. Rohto Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Rohto Pharmaceutical Main Business
Table 127. Rohto Pharmaceutical Latest Developments
Table 128. Kobayashi Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 130. Kobayashi Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Kobayashi Pharmaceutical Main Business
Table 132. Kobayashi Pharmaceutical Latest Developments
Table 133. Kowa Company Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Kowa Company Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 135. Kowa Company Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Kowa Company Main Business
Table 137. Kowa Company Latest Developments
Table 138. Guilin Sanjin Pharmaceutical Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 140. Guilin Sanjin Pharmaceutical Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Guilin Sanjin Pharmaceutical Main Business
Table 142. Guilin Sanjin Pharmaceutical Latest Developments
Table 143. ICPA Health Products Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. ICPA Health Products Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 145. ICPA Health Products Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. ICPA Health Products Main Business
Table 147. ICPA Health Products Latest Developments
Table 148. VistaPharm, Inc. Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. VistaPharm, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 150. VistaPharm, Inc. Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. VistaPharm, Inc. Main Business
Table 152. VistaPharm, Inc. Latest Developments
Table 153. Patterson Dental Supply, Inc. Basic Information, Dental Anti-inflammatory Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Product Portfolios and Specifications
Table 155. Patterson Dental Supply, Inc. Dental Anti-inflammatory Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Patterson Dental Supply, Inc. Main Business
Table 157. Patterson Dental Supply, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Dental Anti-inflammatory Drugs
Figure 2. Dental Anti-inflammatory Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dental Anti-inflammatory Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dental Anti-inflammatory Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dental Anti-inflammatory Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dental Anti-inflammatory Drugs Sales Market Share by Country/Region (2025)
Figure 10. Dental Anti-inflammatory Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Rinse
Figure 12. Product Picture of Oral Gel/Ointment
Figure 13. Product Picture of Oral Spray
Figure 14. Product Picture of Oral Tablets
Figure 15. Product Picture of Oral Powder
Figure 16. Product Picture of Others
Figure 17. Global Dental Anti-inflammatory Drugs Sales Market Share by Type in 2026
Figure 18. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Single-Active-Ingredient Type (1 Active Ingredient)
Figure 20. Product Picture of Multi-Active-Ingredient Type (?2 Active Ingredients)
Figure 21. Global Dental Anti-inflammatory Drugs Sales Market Share by Number of Active Ingredients in 2026
Figure 22. Global Dental Anti-inflammatory Drugs Revenue Market Share by Number of Active Ingredients (2021-2026)
Figure 23. Product Picture of Antimicrobial
Figure 24. Product Picture of Anti-inflammatory
Figure 25. Product Picture of Combined Antimicrobial and Anti-inflammatory
Figure 26. Product Picture of Tissue Repair
Figure 27. Product Picture of Others
Figure 28. Global Dental Anti-inflammatory Drugs Sales Market Share by Pharmacological Action in 2026
Figure 29. Global Dental Anti-inflammatory Drugs Revenue Market Share by Pharmacological Action (2021-2026)
Figure 30. Dental Anti-inflammatory Drugs Consumed in Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
Figure 31. Global Dental Anti-inflammatory Drugs Market: Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.) (2021-2026) & (K Units)
Figure 32. Dental Anti-inflammatory Drugs Consumed in Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
Figure 33. Global Dental Anti-inflammatory Drugs Market: Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.) (2021-2026) & (K Units)
Figure 34. Dental Anti-inflammatory Drugs Consumed in Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
Figure 35. Global Dental Anti-inflammatory Drugs Market: Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.) (2021-2026) & (K Units)
Figure 36. Dental Anti-inflammatory Drugs Consumed in Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
Figure 37. Global Dental Anti-inflammatory Drugs Market: Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.) (2021-2026) & (K Units)
Figure 38. Dental Anti-inflammatory Drugs Consumed in Others
Figure 39. Global Dental Anti-inflammatory Drugs Market: Others (2021-2026) & (K Units)
Figure 40. Global Dental Anti-inflammatory Drugs Sale Market Share by Application (2025)
Figure 41. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application in 2025
Figure 42. Dental Anti-inflammatory Drugs Sales by Company in 2025 (K Units)
Figure 43. Global Dental Anti-inflammatory Drugs Sales Market Share by Company in 2025
Figure 44. Dental Anti-inflammatory Drugs Revenue by Company in 2025 ($ millions)
Figure 45. Global Dental Anti-inflammatory Drugs Revenue Market Share by Company in 2025
Figure 46. Global Dental Anti-inflammatory Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Dental Anti-inflammatory Drugs Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 49. Americas Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 50. APAC Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 51. APAC Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 52. Europe Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 53. Europe Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 55. Middle East & Africa Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 56. Americas Dental Anti-inflammatory Drugs Sales Market Share by Country in 2025
Figure 57. Americas Dental Anti-inflammatory Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Americas Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 59. Americas Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 60. United States Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Dental Anti-inflammatory Drugs Sales Market Share by Region in 2025
Figure 65. APAC Dental Anti-inflammatory Drugs Revenue Market Share by Region (2021-2026)
Figure 66. APAC Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 67. APAC Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 68. China Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. India Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Dental Anti-inflammatory Drugs Sales Market Share by Country in 2025
Figure 76. Europe Dental Anti-inflammatory Drugs Revenue Market Share by Country (2021-2026)
Figure 77. Europe Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 78. Europe Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 79. Germany Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. France Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 87. Egypt Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Dental Anti-inflammatory Drugs in 2026
Figure 93. Manufacturing Process Analysis of Dental Anti-inflammatory Drugs
Figure 94. Industry Chain Structure of Dental Anti-inflammatory Drugs
Figure 95. Channels of Distribution
Figure 96. Global Dental Anti-inflammatory Drugs Sales Market Forecast by Region (2027-2032)
Figure 97. Global Dental Anti-inflammatory Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Dental Anti-inflammatory Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Dental Anti-inflammatory Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Dental Anti-inflammatory Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Dental Anti-inflammatory Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Dental Anti-inflammatory Drugs
Figure 2. Dental Anti-inflammatory Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dental Anti-inflammatory Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Dental Anti-inflammatory Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Dental Anti-inflammatory Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Dental Anti-inflammatory Drugs Sales Market Share by Country/Region (2025)
Figure 10. Dental Anti-inflammatory Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Rinse
Figure 12. Product Picture of Oral Gel/Ointment
Figure 13. Product Picture of Oral Spray
Figure 14. Product Picture of Oral Tablets
Figure 15. Product Picture of Oral Powder
Figure 16. Product Picture of Others
Figure 17. Global Dental Anti-inflammatory Drugs Sales Market Share by Type in 2026
Figure 18. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Single-Active-Ingredient Type (1 Active Ingredient)
Figure 20. Product Picture of Multi-Active-Ingredient Type (?2 Active Ingredients)
Figure 21. Global Dental Anti-inflammatory Drugs Sales Market Share by Number of Active Ingredients in 2026
Figure 22. Global Dental Anti-inflammatory Drugs Revenue Market Share by Number of Active Ingredients (2021-2026)
Figure 23. Product Picture of Antimicrobial
Figure 24. Product Picture of Anti-inflammatory
Figure 25. Product Picture of Combined Antimicrobial and Anti-inflammatory
Figure 26. Product Picture of Tissue Repair
Figure 27. Product Picture of Others
Figure 28. Global Dental Anti-inflammatory Drugs Sales Market Share by Pharmacological Action in 2026
Figure 29. Global Dental Anti-inflammatory Drugs Revenue Market Share by Pharmacological Action (2021-2026)
Figure 30. Dental Anti-inflammatory Drugs Consumed in Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.)
Figure 31. Global Dental Anti-inflammatory Drugs Market: Online Sales (Pharmaceutical E-Commerce Platforms, Online Hospital Marketplaces, Official Brand Stores, etc.) (2021-2026) & (K Units)
Figure 32. Dental Anti-inflammatory Drugs Consumed in Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.)
Figure 33. Global Dental Anti-inflammatory Drugs Market: Hospitals (Dental Departments In General Hospitals, Specialized Dental Hospitals, Pediatric Dental Departments, etc.) (2021-2026) & (K Units)
Figure 34. Dental Anti-inflammatory Drugs Consumed in Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.)
Figure 35. Global Dental Anti-inflammatory Drugs Market: Pharmacies (Chain Retail Pharmacies, Community Pharmacies, etc.) (2021-2026) & (K Units)
Figure 36. Dental Anti-inflammatory Drugs Consumed in Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.)
Figure 37. Global Dental Anti-inflammatory Drugs Market: Clinics (Independent Dental Clinics, Dental Clinic Chains, etc.) (2021-2026) & (K Units)
Figure 38. Dental Anti-inflammatory Drugs Consumed in Others
Figure 39. Global Dental Anti-inflammatory Drugs Market: Others (2021-2026) & (K Units)
Figure 40. Global Dental Anti-inflammatory Drugs Sale Market Share by Application (2025)
Figure 41. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application in 2025
Figure 42. Dental Anti-inflammatory Drugs Sales by Company in 2025 (K Units)
Figure 43. Global Dental Anti-inflammatory Drugs Sales Market Share by Company in 2025
Figure 44. Dental Anti-inflammatory Drugs Revenue by Company in 2025 ($ millions)
Figure 45. Global Dental Anti-inflammatory Drugs Revenue Market Share by Company in 2025
Figure 46. Global Dental Anti-inflammatory Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Dental Anti-inflammatory Drugs Revenue Market Share by Geographic Region in 2025
Figure 48. Americas Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 49. Americas Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 50. APAC Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 51. APAC Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 52. Europe Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 53. Europe Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Dental Anti-inflammatory Drugs Sales 2021-2026 (K Units)
Figure 55. Middle East & Africa Dental Anti-inflammatory Drugs Revenue 2021-2026 ($ millions)
Figure 56. Americas Dental Anti-inflammatory Drugs Sales Market Share by Country in 2025
Figure 57. Americas Dental Anti-inflammatory Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Americas Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 59. Americas Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 60. United States Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Dental Anti-inflammatory Drugs Sales Market Share by Region in 2025
Figure 65. APAC Dental Anti-inflammatory Drugs Revenue Market Share by Region (2021-2026)
Figure 66. APAC Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 67. APAC Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 68. China Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. India Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Dental Anti-inflammatory Drugs Sales Market Share by Country in 2025
Figure 76. Europe Dental Anti-inflammatory Drugs Revenue Market Share by Country (2021-2026)
Figure 77. Europe Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 78. Europe Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 79. Germany Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 80. France Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Dental Anti-inflammatory Drugs Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Dental Anti-inflammatory Drugs Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Dental Anti-inflammatory Drugs Sales Market Share by Application (2021-2026)
Figure 87. Egypt Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Dental Anti-inflammatory Drugs Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Dental Anti-inflammatory Drugs in 2026
Figure 93. Manufacturing Process Analysis of Dental Anti-inflammatory Drugs
Figure 94. Industry Chain Structure of Dental Anti-inflammatory Drugs
Figure 95. Channels of Distribution
Figure 96. Global Dental Anti-inflammatory Drugs Sales Market Forecast by Region (2027-2032)
Figure 97. Global Dental Anti-inflammatory Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Dental Anti-inflammatory Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Dental Anti-inflammatory Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Dental Anti-inflammatory Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Dental Anti-inflammatory Drugs Revenue Market Share Forecast by Application (2027-2032)
